Zobrazeno 1 - 10
of 1 497
pro vyhledávání: '"E David Crawford"'
Autor:
Motohide Uemura, Hiroaki Kikukawa, Yasuhiro Hashimoto, Hiroji Uemura, Atsushi Mizokami, Masashi Kato, Hisashi Matsushima, Takeo Kosaka, Motonobu Nakamura, Satoshi Fukasawa, Matthew R. Smith, Bertrand Tombal, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, E. David Crawford, Haruka Kakiuchi, Masanao Akiyama, Rui Li, Iris Kuss, Heikki Joensuu, Hiroyoshi Suzuki
Publikováno v:
Cancer Medicine, Vol 13, Iss 21, Pp n/a-n/a (2024)
Abstract Background In the global ARASENS study (NCT02799602), darolutamide plus androgen‐deprivation therapy (ADT) and docetaxel significantly reduced risk of death by 32.5% versus placebo plus ADT and docetaxel (hazard ratio [HR] 0.68; 95% confid
Externí odkaz:
https://doaj.org/article/1058407c6e5d4f8494ab24581515bb95
Publikováno v:
European Urology. 55:e90-e91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef169f2485e32446993343cbb61a40e
https://doi.org/10.1016/j.eururo.2008.11.037
https://doi.org/10.1016/j.eururo.2008.11.037
Autor:
Gandaglia G; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy. Electronic address: Giorgio.gandaglia@gmail.com., Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada., Briganti A; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Publikováno v:
European urology [Eur Urol] 2014 Aug; Vol. 66 (2), pp. e36-7. Date of Electronic Publication: 2014 Apr 13.
Autor:
Herjan J.T. Coelingh Bennink, Jeroen A. van Moorselaar, E. David Crawford, Erik P.M. Roos, Diederik M. Somford, Ton A. Roeleveld, Tjard D. de Haan, Harm H.E. van Melick, Yacov Reisman, Yvette Zimmerman, Gonnie van Osta, Jan Krijgh, Neal D. Shore, Fred Saad, Andrew V. Schally, Frans M.J. Debruyne
Publikováno v:
European Urology Open Science, Vol 28, Iss , Pp 52-61 (2021)
Background: Androgen deprivation therapy (ADT) for prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonists can be improved. Objective: To assess safety, the frequency and severity of hot flushes (HFs), bone health, and antitumor ef
Externí odkaz:
https://doaj.org/article/dc4f5a0c31044f3baa728ff536e9797f
Publikováno v:
European urology [Eur Urol] 2009 May; Vol. 55 (5), pp. e88-9; author reply e90-1. Date of Electronic Publication: 2008 Nov 29.
Publikováno v:
European Urology. 55:e88-e89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcbb89f5e428b75b50c17d95b6212dcb
https://doi.org/10.1016/j.eururo.2008.11.036
https://doi.org/10.1016/j.eururo.2008.11.036